ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by nobody – 2020-02-12 09:49 (1729 d 23:10 ago) – Posting: # 21163
Views: 8,774

❝ ❝ Art.75. For two-stage studies, the following should be noted: It is acceptable to use a two-stage approach to demonstrate bioequivalence based on ignorance of the intra-individual variability of the drug;



❝ Ermmm...... WHAT???? :-D:party:


Same reaction here last night, but I thought I'm hallucinating due to ovewr-day fasting.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,288 posts in 4,890 threads, 1,661 registered users;
90 visitors (0 registered, 90 guests [including 11 identified bots]).
Forum time: 08:59 CET (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5